VERU INC. Lessee, Operating Lease, Liability, to be Paid, Year One
VERU INC. (VERU) had Lessee, Operating Lease, Liability, to be Paid, Year One of $788.47 thousand as of 2025-09-30, per its 10-K filed 2025-12-17.
Financial Statements › Notes › Lessee, Operating Lease, Liability, to be Paid, Fiscal Year Maturity
us-gaap:LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths · last filed 2025-12-17
- 2025-09-30: Lessee, Operating Lease, Liability, to be Paid, Year One $788.47K.
- 2024-09-30: Lessee, Operating Lease, Liability, to be Paid, Year One $1.11M.
- 2023-09-30: Lessee, Operating Lease, Liability, to be Paid, Year One $1.09M.
- 2022-09-30: Lessee, Operating Lease, Liability, to be Paid, Year One $1.00M.
| Period end | Lessee, Operating Lease, Liability, to be Paid, Year One |
|---|---|
| 2025-09-30 | $788.47K 10-K · filed 2025-12-17 |
| 2024-09-30 | $1.11M 10-K · filed 2024-12-16 |
| 2023-09-30 | $1.09M 10-K/A · filed 2024-04-01 |
| 2022-09-30 | $1.00M 10-K · filed 2022-12-05 |
| 2022-06-30 | $1.02M 10-Q · filed 2022-08-11 |
| 2022-03-31 | $1.04M 10-Q · filed 2022-05-12 |
| 2021-09-30 | $527.21K 10-K · filed 2021-12-02 |
| 2020-09-30 | $621.66K 10-K · filed 2020-12-10 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Kairos Pharma, LTD. (KAPA) | United States | $0.041B | |
| SCYNEXIS INC (SCYX) | United States | $0.045B | |
| PDS Biotechnology Corp (PDSB) | United States | $0.045B | |
| Incannex Healthcare Inc. (IXHL) | $0.040B | -22.32 | |
| Grace Therapeutics, Inc. (GRCE) | $0.046B | -1.83 | |
| Karyopharm Therapeutics Inc. (KPTI) | United States | $0.039B | -0.98 |
| Edesa Biotech, Inc. (EDSA) | Canada | $0.039B | |
| Werewolf Therapeutics, Inc. (HOWL) | United States | $0.047B | |
| CervoMed Inc. (CRVO) | United States | $0.038B | -1.39 |
| Celularity Inc (CELU) | United States | $0.038B | -0.34 |